Biochemical Recurrence Clinical Trials

4 recruiting

Biochemical Recurrence Trials at a Glance

9 actively recruiting trials for biochemical recurrence are listed on ClinicalTrialsFinder across 6 cities in 4 countries. The largest study group is Phase 2 with 3 trials, with the heaviest enrollment activity in Freiburg im Breisgau, Nanjing, and Augsburg. Lead sponsors running biochemical recurrence studies include The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, Instituto de Investigación en Oncología Radioterápica - Fundación Española de Oncología Radioterápic, and Heinrich-Heine University, Duesseldorf.

Browse biochemical recurrence trials by phase

Treatments under study

About Biochemical Recurrence Clinical Trials

Looking for clinical trials for Biochemical Recurrence? There are currently 4 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Biochemical Recurrence trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Biochemical Recurrence clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 19 of 9 trials

Recruiting

PROCARE - PROstate Cancer Real World Evidence Registry

Prostate CancerNon-metastatic Castration-resistant Prostate CancerBiochemical Recurrence of Malignant Neoplasm of Prostate
UroTrials Company (GmbH)5,000 enrolled53 locationsNCT06835218
Recruiting

A Prospective, Bicentric Evaluation of Fluciclovine PET-imaging in Patients with Prior Negative or Inconclusive PSMA-ligand PET

Biochemical Recurrence of Malignant Neoplasm of Prostate
Technical University of Munich94 enrolled2 locationsNCT06859203
Recruiting

Diagnostic Performance of [18F]PSMA-1007 in the Context of Biochemical Recurrence of Prostate Cancer

Biochemical Recurrence of Malignant Neoplasm of ProstateProstate Cancer After a Radical TreatmentBiochemical Persistence of Prostate Cancer
Heinrich-Heine University, Duesseldorf250 enrolled1 locationNCT06657131
Recruiting
Phase 3

68Ga-PSMA-11 Efficacy in Detecting BCR Prostate Cancer in Chinese Patients

Prostate CancerBiochemical Recurrence of Malignant Neoplasm of ProstateBCR Prostate Carcinoma
Telix Pharmaceuticals (Innovations) Pty Limited110 enrolled8 locationsNCT05847348
Recruiting
Phase 2

Salvage Radiotherapy Combined With Androgen Deprivation Therapy (ADT) With or Without Rezvilutamide in the Treatment of Biochemical Recurrence After Radical Prostatectomy for Prostate Cancer

Prostate CancerBiochemical Recurrence
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School102 enrolled2 locationsNCT06305832
Recruiting
Phase 3

Short Versus Long-term Androgen Deprivation Therapy With Salvage Radiotherapy in Prostate Cancer. URONCOR 0624

Prostate CancerAndrogen Deprivation TherapyBiochemical Recurrence+2 more
Instituto de Investigación en Oncología Radioterápica - Fundación Española de Oncología Radioterápic534 enrolled17 locationsNCT05781217
Recruiting
Phase 2

Rezvilutamide in Patients With Biochemical Recurrence After Radical Prostatectomy for Prostate Cancer

Prostate CancerBiochemical Recurrence
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School96 enrolled2 locationsNCT05753566
Recruiting
Phase 2

SRT in Combination With Pembrolizumab in Patients With Recurrent Prostate Cancer After Radical Prostatectomy

Urologic CancerBiochemical Recurrence of Malignant Neoplasm of Prostate
Prof. Dr. med. Christian Gratzke49 enrolled1 locationNCT04931979
Recruiting
Not Applicable

Salvage Hypofractionated Accelerated Versus Standard Radiotherapy for Biochemical Failure After Prostatectomy

RadiationProstate CancerQuality of Life+5 more
Asan Medical Center288 enrolled2 locationsNCT03920033